Investors

Press Releases

All Releases

View Summary Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
Mar 24, 2016
PDF 14.7 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Praluent® (alirocumab) Study in Patients Undergoing LDL Apheresis Therapy
Mar 23, 2016
PDF 21.7 KB Add to Briefcase
View Summary Regeneron and Sanofi Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal
Mar 16, 2016
PDF 20.5 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
Mar 11, 2016
PDF 20.1 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Humana Provides Exclusive or Preferred Access to Praluent® (alirocumab) Injection on their Commercial and Medicare Formularies
Mar 4, 2016
PDF 17.2 KB Add to Briefcase
View Summary Regeneron Genetics Center Publication in New England Journal of Medicine Links ANGPTL4 Inhibition and Risk of Coronary Artery Disease
Mar 2, 2016
PDF 15.9 KB Add to Briefcase
  Regeneron Hires David Weinreich, M.D., M.B.A., as Senior Vice President, Late Stage Clinical Development and Medical Affairs
Mar 1, 2016
PDF 97.0 KB Add to Briefcase
View Summary Regeneron Announces Upcoming 2016 Investor Conference Presentation
Feb 29, 2016
PDF 9.9 KB Add to Briefcase
View Summary Regeneron Joins Human Vaccines Project to Improve Global Disease Prevention and Treatment
Feb 10, 2016
PDF 12.7 KB Add to Briefcase
View Summary Regeneron Reports Fourth Quarter and Full Year 2015 Financial and Operating Results
Feb 9, 2016
PDF 55.0 KB Add to Briefcase
View Summary Regeneron Announces Upcoming 2016 Investor Conference Presentation
Feb 2, 2016
PDF 9.9 KB Add to Briefcase
  Regeneron and Sanofi Announce Publication of Positive Phase 2 Dupilumab Data in the Journal of the American Medical Association
Feb 2, 2016
PDF 66.3 KB Add to Briefcase
View Summary Regeneron to Report Fourth Quarter and Full Year 2015 Financial and Operating Results and Host Conference Call and Webcast on February 9, 2016
Jan 26, 2016
PDF 9.4 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Sarilumab Biologics License Application Accepted for Review by US FDA
Jan 8, 2016
PDF 162.0 KB Add to Briefcase
View Summary Regeneron Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference
Jan 7, 2016
PDF 68.0 KB Add to Briefcase
View Summary Regeneron Mourns Passing of Dr. Alfred G. Gilman, Board Member and Nobel Laureate
Dec 27, 2015
PDF 9.6 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce UnitedHealth Group Selects Praluent® (alirocumab) Injection for Preferred Access
Dec 11, 2015
PDF 20.2 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled
Nov 24, 2015
PDF 20.7 KB Add to Briefcase
View Summary Regeneron Celebrates Patient Innovation and Growth in New York State
Nov 12, 2015
PDF 5.9 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce New Praluent® (alirocumab) Injection Analyses Presented at AHA Scientific Sessions 2015
Nov 10, 2015
PDF 21.8 KB Add to Briefcase
Showing 21-40 of 340 Page: 1 2 3 4 5 6 ... 17  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase


Close
Form content here please :)